SCHEMBL7655069

SCHEMBL7655069

CCC(=O)c1cc(C(=O)Nc2ccc3c(c2CC)CNCC3(C)C)ccc1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
KMT2A Q03164 1/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MAPT P10636 3/20 0.36
MAPK1 P28482 2/20 0.36
PDE4D Q08499 2/20 0.36
AHR P35869 1/20 0.36
ALDH1A1 P00352 4/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
CHEK1 O14757 1/20 0.35
PIM1 P11309 1/20 0.35
MAPK8 P45983 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
HPGD P15428 2/20 0.35
HDAC8 Q9BY41 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658509 0.92 HDAC1 (0.41) KDM4EKMT2AHDAC1HDAC6PKM
SCHEMBL7655350 0.85 PDE4D (0.42) KDM4EKMT2AHDAC1HDAC6SMN1; SMN2
SCHEMBL7661553 0.84 CREBBP (0.43) KMT2AHDAC1HDAC6SMN1; SMN2HDAC8
SCHEMBL7662267 0.81 POLB (0.49) KDM4EKMT2AHDAC1HDAC6SMN1; SMN2
SCHEMBL7653818 0.81 MAPT (0.47) KDM4EKMT2AHDAC1HDAC6SMN1; SMN2
SCHEMBL7662221 0.74 CREBBP (0.44) KMT2AHDAC1HDAC6SMN1; SMN2HDAC8
SCHEMBL6802166 0.73 GAA (0.42) KMT2APKMSMN1; SMN2MAPTALDH1A1
SCHEMBL7658508 0.73 MAPT (0.42) KDM4EKMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL7662210 0.72 MAPT (0.46) KDM4EKMT2AHDAC1HDAC6MAPT
SCHEMBL7655287 0.72 MAPT (0.41) KDM4EKMT2AHDAC1HDAC6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492378-B1 Substituted isoquinoline derivatives and their use as anticonvulsivants SMITHKLINE BEECHAM P.L.C. (GB) 2002-12-10 US claimed
EP-1104404-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2001-06-06 EP claimed
WO-2000009486-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSIVANTS SMITHKLINE BEECHAM P.L.C. (GB) 2000-02-24 WO claimed
US-6492378-B1 Substituted isoquinoline derivatives and their use as anticonvulsivants SMITHKLINE BEECHAM P.L.C. (GB) 2002-12-10 US disclosed
EP-1104404-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2001-06-06 EP disclosed
WO-2000009486-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSIVANTS SMITHKLINE BEECHAM P.L.C. (GB) 2000-02-24 WO disclosed